Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy – reaching beyond germline BRCA mutations
- Authors:
- E Swisher, I McNeish, RL Coleman, JD Brenton, SH Kaufmann, A Allen, M Raponi, H Giordano, L Maloney, J Isaacson, JA Ledermann
- Journal:
- CANCER RESEARCH
- Citation info:
- 74(19)
- Publication date:
- 1st Aug 2014
- Full text
- DOI